×
Seagen

Seagen

Biotechnology company · seagen.com
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Wikipedia
CEO: David R. Epstein (Nov 9, 2022–)
Parent organization: Pfizer
Headquarters: Bothell, WA
Founded: July 15, 1997
Company value: $43.15 Billion

Seagen is a global team of scientists, engineers, clinicians, advocates, and innovators with a shared commitment to transforming cancer care. We're dedicated to ...
People also ask
Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise ...
Dec 14, 2023 · (NASDAQ: SGEN), a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its ...
Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, ...
Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in commercializing ...
Seagen from www.pfizer.com
At Pfizer, we've shown how we can move with urgency to deliver breakthroughs that change patients' lives. And now, we're making significant investments to ...
Seagen from www.seattletimes.com
Apr 3, 2024 · Pfizer's closure of a Seagen plant in Everett will cost 119 workers their jobs in June, according to a notice released Wednesday by the ...